Clinical Trials Register

Trials with a EudraCT protocol (371)
Paediatric studies in scope of Art45 of the Paediatric Regulation (1,733)

371 result(s) found for: Ear. Displaying page 8 of 19.

EudraCT Number: 2016-000316-15

Sponsor Protocol Number: 523079.01.114

Start Date*: 2016-09-17

Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG

Full Title: Clinical Trial to Explore Treatment Effects of Ginkgo biloba Extract EGb 761® in Patients with Different Types of Vertigo and Effect Modification by Type of Vertigo, Chronicity and Concomitant Path...

Medical condition: Different types of vertigo

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10013993 - Ear and labyrinth disorders	10047340	Vertigo	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PL (Completed)

Trial results: View results

EudraCT Number: 2005-000752-32

Sponsor Protocol Number: 04T-617

Start Date*: 2006-01-23

Sponsor Name:Klinikum Grosshadern

Full Title: Medical treatment of Menière’s disease with betahistine: a placebo-controlled, dose-finding study

Medical condition: Ménière’s disease is a disorder of the inner ear membranous labyrinth characterized by paroxysmal vertiginous attacks, fluctuating sensorineural hearing loss, aural fullness, and tinnitus .The unde...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10027183	Meniere's disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2011-005102-30	Sponsor Protocol Number: OVG2011/05	Start Date*: 2011-12-08
Sponsor Name:University of Oxford
Full Title: A phase III randomised, open label clinical trial evaluating the immunogenicity of a 10-valent pneumococcal conjugate vaccine booster compared to the standard 13-valent pneumococcal conjugate vacci...
Medical condition: The study will include healthy children who have already been vaccinated with 2 doses of Prevenar 13 according to the UK routine immunisation schedule at 2 and 4 months of age. Both vaccines used i...
Disease:
Population Age: Infants and toddlers, Under 18		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2014-000303-28

Sponsor Protocol Number: MW029

Start Date*: 2014-09-29

Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG

Full Title: Multi-center, prospective, controlled, randomized, single-blinded study to evaluate the efficacy of vibrotactile neuro-feedback additionally to intake of Ginkgo biloba special extract EGb 761® for ...

Medical condition: Presby Vertigo

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10013993 - Ear and labyrinth disorders	10047340	Vertigo	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2016-000766-29

Sponsor Protocol Number: 104-201610

Start Date*: 2016-07-29

Sponsor Name:Otonomy Inc.

Full Title: A 6-MONTH, MULTICENTER, PHASE 3, OPEN-LABEL EXTENSION SAFETY STUDY OF OTO-104 GIVEN AT 3-MONTH INTERVALS BY INTRATYMPANIC INJECTION IN SUBJECTS WITH UNILATERAL MENIERE’S DISEASE

Medical condition: Meniere's disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10013993 - Ear and labyrinth disorders	10027183	Meniere's disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended) BE (Completed) DE (Completed) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2022-000624-37

Sponsor Protocol Number: CLOBOF3-17IA03

Start Date*: 2022-10-05

Sponsor Name:Laboratorios Salvat, S.A.

Full Title: A Phase 3, multicenter, randomized, evaluator-blinded clinical trial to assess the safety and efficacy of Clobetasol propionate ophthalmic nanoemulsion, 0.05% compared to Prednisolone acetate, 1% i...

Medical condition: Inflammation and pain associated with ocular surgery.

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10015919 - Eye disorders	10015943	Eye inflammation	PT
	20.0	10015919 - Eye disorders	10015958	Eye pain	PT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-002923-37

Sponsor Protocol Number: 2022-ENT-FESS-nonFESS

Start Date*: 2023-04-25

Sponsor Name:Department of Otorhinolaryngology Head & Neck and Audiology, Rigshospitalet, Copenhagen, Denmark

Full Title: Optimisation of treatment in patients with CRSwNP. An RCT of mepolizumab and surgical treatment with FESS and mepolizumab versus only mepolizumab over a 6- and 12-month follow-up

Medical condition: Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10038738 - Respiratory, thoracic and mediastinal disorders	10080060	Chronic rhinosinusitis with nasal polyps	PT
	20.0	10038738 - Respiratory, thoracic and mediastinal disorders	10003553	Asthma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2013-003990-89

Sponsor Protocol Number: Uni-Koeln-1707

Start Date*: 2015-05-12

Sponsor Name:University of Cologne

Full Title: Brentuximab vedotin or B-CAP in the treatment of older patients with newly diagnosed classical Hodgkin Lymphoma – a GHSG-NLG Intergroup Phase II trial –

Medical condition: Treatment of older patients with newly diagnosed classical Hodgkin lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10005329 - Blood and lymphatic system disorders	10025319	Lymphomas Hodgkin's disease	HLGT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) NO (Completed) SE (Completed) DK (Completed) FI (Completed)

Trial results: View results

EudraCT Number: 2018-003446-16

Sponsor Protocol Number: ATX-ME-001

Start Date*: 2022-07-27

Sponsor Name:Achilles Therapeutics UK Limited

Full Title: An open-label, multi-centre, phase I/IIa study evaluating the safety and clinical activity of neoantigen reactive T cells in patients with metastatic or recurrent melanoma.

Medical condition: Metastatic or recurrent melanoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10072454	Amelanotic melanoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10072452	Angiotropic melanoma	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10072447	Blue naevus-like melanoma	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10072453	Blue nevus-like melanoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10072449	Desmoplastic melanoma	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025650	Malignant melanoma	PT
	21.1	100000004865	10025651	Malignant melanoma excision	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10063706	Malignant melanoma of eyelid	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025653	Malignant melanoma of other specified sites of skin	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025655	Malignant melanoma of skin	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025656	Malignant melanoma of skin of ear and external auditory canal	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025657	Malignant melanoma of skin of ear and external auricular canal	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10056767	Malignant melanoma of skin of eyelid, incl canthus	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025658	Malignant melanoma of skin of eyelid, including canthus	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025659	Malignant melanoma of skin of lip	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10056768	Malignant melanoma of skin of lower limb, incl hip	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025660	Malignant melanoma of skin of lower limb, including hip	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025661	Malignant melanoma of skin of other and unspecified parts of face	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025662	Malignant melanoma of skin of scalp and neck	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025663	Malignant melanoma of skin of trunk, except scrotum	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10056792	Malignant melanoma of skin of trunk, excl scrotum	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10056769	Malignant melanoma of skin of upper limb, incl shoulder	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025664	Malignant melanoma of skin of upper limb, including shoulder	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025670	Malignant melanoma stage III	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025671	Malignant melanoma stage IV	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10053571	Melanoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027149	Melanoma limited to extremity	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027150	Melanoma malignant	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10048434	Melanoma malignant aggravated	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027152	Melanoma of skin (malignant)	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027153	Melanoma of skin, site unspecified	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027154	Melanoma of trunk and head	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10066600	Melanoma recurrent	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027155	Melanoma skin	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027480	Metastatic malignant melanoma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027481	Metastatic melanoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10079054	Naevoid melanoma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10079068	Nevoid melanoma	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029488	Nodular melanoma	PT
	20.0	100000004865	10074800	Skin malignant melanoma excision	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10040891	Skin melanoma	LLT
	20.0	100000004858	10027156	Skin melanomas (excl ocular)	HLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10042547	Superficial spreading melanoma	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10042551	Superficial spreading melanoma stage III	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10042552	Superficial spreading melanoma stage IV	PT
	21.1	100000004865	10047981	Wide excision of melanoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing) DE (Completed)

Trial results: (No results available)

EudraCT Number: 2009-011246-25

Sponsor Protocol Number: MRZ 92579/TI/3003

Start Date*: 2009-11-04

Sponsor Name:Merz Pharmaceuticals GmbH

Full Title: MRZ 92579/TI/3003: A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients with Subjective Tinnitus

Medical condition: Subjective Tinnitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	13.1	10013993 - Ear and labyrinth disorders	10042398	Subjective tinnitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2017-003846-26

Sponsor Protocol Number: C-05-69

Start Date*: 2017-11-19

Sponsor Name:Alcon Research Ltd

Full Title: Safety Study of Olopatadine Nasal Spray

Medical condition: perennial allergic rhinitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004855	10034382	Perennial allergic rhinitis	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: Outside EU/EEA

Trial results: View results

EudraCT Number: 2007-000190-28

Sponsor Protocol Number: IMD-10412002-1

Start Date*: 2007-03-22

Sponsor Name:Institute of Medicinal Molecular Design Inc

Full Title: A Single Centre, Double-blind, Randomised Study To Investigate a Single Oral Dose of IMD-1041 in A Nasal Allergen Challenge (NAC) Model

Medical condition: It is intended to investigate the potential therapeutic benefit of IKKβ inhibition in man by oral dosing of IMD-1041 in a Nasal Alllergen Challenge.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10042613 - Surgical and medical procedures	10053467	Antiinflammatory therapy	PT

Population Age: Adults

Gender: Male

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2012-004194-12	Sponsor Protocol Number: CS-BM32-nasal-001	Start Date*: 2012-10-23
Sponsor Name:Medizinische Universität Wien, HNO Klinik
Full Title: The effect of BM32, a recombinant hypoallergenic vaccine for immunotherapy of grass pollen allergy, on immunoglobulin levels in nasal secretions of patients suffering from seasonal allergic rhinitis
Medical condition: Grass pollen allergy
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: AT (Completed)
Trial results: View results

EudraCT Number: 2005-005339-83

Sponsor Protocol Number: IPA101985

Start Date*: 2006-05-19

Sponsor Name:GlaxoSmithKline Research & Development Limited

Full Title: A two-centre, randomised, double-blind, placebo-controlled, 2-period cross-over study to evaluate the effect of treatment with repeat doses of inhaled GSK256066 on the allergen-induced late asthmat...

Medical condition: Allergen-induced late asthmatic response

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10003567		LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2006-000067-29	Sponsor Protocol Number: 310101	Start Date*: 2006-07-04
Sponsor Name:Bayer Schering Pharma AG
Full Title: Phase I/II study to investigate the safety, tolerability, efficacy and pharmacokinetics of ZK 219477 in combination with cisplatin as first-line therapy in chemotherapy-naive patients with extensiv...
Medical condition: Extensive disease (ED) stage small-cell lung cancer (SCLC)
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2004-000576-13	Sponsor Protocol Number: INO102141	Start Date*: 2004-11-03
Sponsor Name:GlaxoSmithKline Research & Development Limited
Full Title: A two-centre, randomised, double-blind, double-dummy, placebo-controlled, 3-period cross-over study to evaluate the effect of treatment with repeat doses of GW274150 on the allergen-induced late as...
Medical condition: Mild asthma
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2020-001027-13

Sponsor Protocol Number: SELK2-00006

Start Date*: 2020-06-29

Sponsor Name:Tetherex Pharmaceuticals Corporation

Full Title: A Two Part, Randomised, Double-blind, Placebo-controlled, Phase 2 Parallel Group Study to Evaluate the Safety and Efficacy of Intravenously-Administered SelK2 on Airway Responses Following Allergen...

Medical condition: Part 1: Asthma Part 2: Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10038738 - Respiratory, thoracic and mediastinal disorders	10003553	Asthma	PT
	21.1	10038738 - Respiratory, thoracic and mediastinal disorders	10009033	Chronic obstructive pulmonary disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2012-004900-37	Sponsor Protocol Number: DC05/RUP/I/13	Start Date*: 2012-11-20
Sponsor Name:J. Uriach y Compañía, S.A.
Full Title: A Phase I, Randomised, Double-blind, Placebo-controlled, Parallel group study to assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of oral Rupatadine in Healthy Japanese Subjec...
Medical condition: This is a Phase I study in helathy subjects. No condition is being treated. The IMP is approved for symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents (over 12 yea...
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)

EudraCT Number: 2010-023311-34

Sponsor Protocol Number: CPA 368-10

Start Date*: 2011-02-04

Sponsor Name:AOP Orphan Pharmaceuticals AG

Full Title: A prospective, randomized, double blinded, crossover, two-treatment, two-sequence, short term pharmacokinetic, pharmacodynamic and tolerability, single centre study to compare AOP200704 vs. Esmolol...

Medical condition: healthy male and female volunteers, intended for the treatment of dobutamine-induced tachycardia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10040752	Sinus tachycardia	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2014-002179-27

Sponsor Protocol Number: AUT032063

Start Date*: 2014-08-29

Sponsor Name:Autifony Therapeutics Limited

Full Title: A Balanced Randomised Placebo Controlled Double-blind Phase IIa Study to Investigate the Efficacy and Safety of AUT00063 Versus Placebo in Subjective Tinnitus

Medical condition: Subjects suffering with noise and/or age-related tinnitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.1	100000004854	10042398	Subjective tinnitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Ear